metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Most often read
Journal Information

Most often read

4062
Neurological manifestations associated with COVID-19 vaccine
R. Alonso Castillo, J.C. Martínez Castrillo
Neurologia. 2025;40:66-76
4062
Full text access
2878
Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations
D. Santos García, J. Pagonabarraga Mora, F. Escamilla Sevilla, P.J. García Ruiz, J. Infante Ceberio, J. Kulisevsky Bojarski, G. Linazasoro Cristóbal, M.R. Luquín Piudo, ... Panel of Experts Phase 1
Neurologia. 2025;40:171-81
2878
Full text access
2205
Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology’s Headache Study Group
J. García-Ull, N. González-García, M. Torres-Ferrús, D. García-Azorín, I.F.J. Molina-Martínez, I. Beltrán-Blasco, S. Santos-Lasaosa, G. Latorre, ... P. Irimia
Neurologia. 2025;40:118-37
2205
Full text access
2067
A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
M.-C. Boll, M. Alcaraz-Zubeldia, C. Rios, D. González-Esquivel, S. Montes
Neurologia. 2025;40:32-40
2067
Full text access
1909
Mortality rates for Parkinson’s disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020
C. García-Muñoz, J.C. Hernández-Rodríguez, J.J. Pereyra-Rodriguez
Neurologia. 2025;40:161-70
1909
Full text access
1528
Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis
U. Gomez-Pinedo, J.A. Matías-Guiu, L. Torre-Fuentes, P. Montero-Escribano, L. Hernández-Lorenzo, V. Pytel, P. Maietta, S. Alvarez, ... J. Matías-Guiu
Neurologia. 2025;40:10-21
1528
Full text access
1401
Exonic variants of the P2RX7 gene in familial multiple sclerosis
U. Gómez-Pinedo, L. Torre-Fuentes, J.A. Matías-Guiu, V. Pytel, D.D. Ojeda-Hernández, B. Selma-Calvo, P. Montero-Escribano, L. Vidorreta-Ballesteros, J. Matías-Guiu
Neurologia. 2025;40:150-60
1401
Full text access
1305
Barcelona scale for buccophonatory apraxia: Quantitative assessment tool
N. Montagut, S. Borrego-Écija, J. Herrero, A. Lladó, M. Balasa, E. Muñoz, F. Valldeoriola, R. Sánchez-Valle
Neurologia. 2025;40:48-56
1305
Full text access
1233
A variant in GRN of Spanish origin presenting with heterogeneous phenotypes
M. Menéndez-González, A. García-Martínez, I. Fernández-Vega, A. Pitiot, V. Álvarez
Neurologia. 2025;40:57-65
1233
Full text access
1130
The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis
O. Mirmosayyeb, V. Shaygannejad, N. Ebrahimi, H. Ghoshouni, M. Ghajarzadeh
Neurologia. 2025;40:41-7
1130
Full text access
1110
The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis
V. Shaygannejad, O. Mirmosayyeb, S. Vaheb, N. Nehzat, M. Ghajarzadeh
Neurologia. 2025;40:22-31
1110
Full text access
1109
Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry
J. Tejada García, L.B. Lara Lezama, R. de la Fuente Blanco, A. Pérez de Prado, L. Benavente Fernández, M. Rico Santos, M.D. Fernández Couto, L. Naya Ríos, ... M. Martínez Zabaleta
Neurologia. 2025;40:139-49
1109
Full text access
1031
Psychological discomfort in carriers and non-carriers of the Huntington disease mutation and its relationship with disease burden
Y. Rodríguez-Agudelo, M. Chávez-Oliveros, A. Ochoa-Morales, L. Martínez-Ruano, A. Camacho-Molina, F. Paz-Rodríguez
Neurologia. 2025;40:1-9
1031
Full text access
878
Opsoclonus-myoclonus syndrome and prostate cancer. An entity to be aware of
C. Guijarro-Castro, L. Estallo-Guijarro
Neurologia. 2025;40:216-7
878
Full text access
728
Guideline: Neurorehabilitation in patients with disorder of consciousness. Recommendations from the Spanish Society of Neurorehabilitation
E. Noé, M.D. Navarro, B. Moliner, M. O’Valle, J. Olaya, A. Maza, R. Llorens, J. Ferri, ... on behalf of the Spanish Society of Neurorehabilitation
Neurologia. 2025;40:92-117
728
Full text access
642
Mutations in the type IV collagen gen (COL4A1) as an unusual etiology of cerebrovascular disease in young adults
J. Martín Prieto, E. García-Serrano Fuertes, J. Iglesias Bermejillo, A. Luna Rodríguez
Neurologia. 2025;40:217-20
642
Full text access
462
Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
Juan Marta-Enguita, Florencio J.D. Machado, Josune Orbe, Roberto Muñoz
Neurologia. 2025;40:77-88
462
Full text access
310
Focusing on post-COVID syndrome fatigue
M. Gómez-Eguílaz, S. López-Alava, J.L. Ramón-Trapero, F. Castillo-Álvarez, N. Gómez Loizaga, C. García-Penco, N. Boukichou-Abdelkader, L. Pérez-Martínez
Neurologia. 2025;40:204-15
310
Full text access
209
The current situation of Telestroke in Spain
A. Barragán-Prieto, S. Pérez-Sánchez, M. Castellanos, A. González, J. Montaner
Neurologia. 2025;40:182-90
209
Full text access
156
Clinical variability in STIM1 variant c.262A>G associated with Stormorken syndrome
L. Silva-Hernández, B. Cabal-Paz, J. Jiménez-Almonacid, E. González-Vioque, J. Bohm
Neurologia. 2025;40:89-91
156
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos